Clinical trial: 17 volunteers given Sputnik V vaccine in Pune
PTI, Dec 6, 2020, 5:55 PM IST
Pune: A total of 17 volunteers have been administered Russia’s Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said on Sunday.
Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.
“Seventeen healthy volunteers were administered Sputnik V vaccine in the last three days as part of human trials,” Dr S K Raut, Head of Clinical Research Department of Noble Hospital here, said.
The inoculation process began on Thursday, he added.
“All the volunteers, who were administered the vaccine, will be under observation for the next few days,” Dr Raut added.
The selection of the volunteers was done as per the laid-down norms as they need to be healthy, doctors said.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Five arrested in connection with botched angioplasty deaths at Gujarat hospital
Deceased Kannur official’s widow moves Kerala HC for CBI probe into his death
Kerala CM accuses Centre of turning ‘blind-eye’ towards Wayanad’s need for help
Construct iconic deep tech building in Amaravati, Andhra CM tells officials
Mumbai court sentences man to life imprisonment for killing son over his refusal to call 2nd wife mother
MUST WATCH
Latest Additions
Five arrested in connection with botched angioplasty deaths at Gujarat hospital
Deceased Kannur official’s widow moves Kerala HC for CBI probe into his death
CAMPCO urges Centre to take action on areca nut ‘carcinogen classification’
Nagarjuna’s younger son Akhil Akkineni engaged
Kerala CM accuses Centre of turning ‘blind-eye’ towards Wayanad’s need for help
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.